The growth in the peripheral intravenous catheter market is driven by several factors, including advancements in catheter technology, an increase in the prevalence of chronic diseases, and a rising emphasis on healthcare quality and patient safety. The aging population globally has led to a higher incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases, all of which often require IV therapeutic treatment modalities. Additionally, the growing trend towards minimally invasive treatments has fueled the demand for devices that can be efficiently managed in outpatient settings, including home healthcare. The market is also benefiting from the increasing investment in healthcare infrastructure and services, particularly in emerging economies where access to basic medical care is expanding. Furthermore, ongoing research and development activities aimed at further minimizing infection rates and improving patient comfort are poised to propel the adoption of newer, more advanced peripheral IV catheter products. This market dynamic is supported by a competitive landscape where manufacturers are continually innovating to meet the stringent safety standards required by regulatory authorities worldwide, ensuring sustained growth in this sector.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Short Catheters segment, which is expected to reach US$4.6 Billion by 2030 with a CAGR of a 5.0%. The Integrated / Closed Catheters segment is also set to grow at 6.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 9.0% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Intravenous (IV) Catheters Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Intravenous (IV) Catheters Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Peripheral Intravenous (IV) Catheters Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Argon Medical Devices, Inc., B. Braun Medical Inc., Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 45 Featured):
- Argon Medical Devices, Inc.
- B. Braun Medical Inc.
- Becton, Dickinson and Company
- ICU Medical, Inc.
- MEDEREN Neotech Ltd
- Nipro Medical Corporation
- Delta Med S.p.A
- Vogt Medical GMBH
- Teleflex, Inc.
- Terumo Medical Corporation
- Vygon SAS;
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Argon Medical Devices, Inc.
- B. Braun Medical Inc.
- Becton, Dickinson and Company
- ICU Medical, Inc.
- MEDEREN Neotech Ltd
- Nipro Medical Corporation
- Delta Med S.p.A
- Vogt Medical GMBH
- Teleflex, Inc.
- Terumo Medical Corporation
- Vygon SAS;
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 372 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 5.2 Billion |
Forecasted Market Value ( USD | $ 7.7 Billion |
Compound Annual Growth Rate | 5.6% |
Regions Covered | Global |